1. Home
  2. GKOS vs PNR Comparison

GKOS vs PNR Comparison

Compare GKOS & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$185.49

Market Cap

10.9B

Sector

Health Care

ML Signal

N/A

Logo Pentair plc.

PNR

Pentair plc.

N/A

Current Price

$66.07

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
PNR
Founded
1998
1966
Country
United States
United Kingdom
Employees
1094
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
10.1B
IPO Year
2015
2003

Fundamental Metrics

Financial Performance
Metric
GKOS
PNR
Price
$185.49
$66.07
Analyst Decision
Strong Buy
Buy
Analyst Count
12
16
Target Price
$126.92
$109.73
AVG Volume (30 Days)
855.1K
3.2M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
N/A
1.34%
EPS Growth
N/A
5.88
EPS
N/A
1.05
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$4.24
Revenue Next Year
$27.43
$4.82
P/E Ratio
N/A
$63.68
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$57.60
52 Week High
$189.69
$113.95

Technical Indicators

Market Signals
Indicator
GKOS
PNR
Relative Strength Index (RSI) 74.68 44.23
Support Level $99.75 $57.60
Resistance Level N/A $77.03
Average True Range (ATR) 7.77 1.91
MACD 1.39 0.29
Stochastic Oscillator 88.29 30.91

Price Performance

Historical Comparison
GKOS
PNR

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PNR Pentair plc.

Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.

Share on Social Networks: